You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Lidocaine Hydrochloride 0.4% In Dextrose 5%, and when can generic versions of Lidocaine Hydrochloride 0.4% In Dextrose 5% launch?

Lidocaine Hydrochloride 0.4% In Dextrose 5% is a drug marketed by Hospira and is included in two NDAs.

The generic ingredient in LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% is lidocaine hydrochloride. There are twenty-nine drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the lidocaine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Lidocaine Hydrochloride 0.4% In Dextrose 5%

A generic version of LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% was approved as lidocaine hydrochloride by WOCKHARDT BIO AG on November 18th, 1982.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%?
  • What are the global sales for LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%?
  • What is Average Wholesale Price for LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%?
Summary for LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%
Drug patent expirations by year for LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%
Recent Clinical Trials for LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sichuan Cancer Hospital and Research InstituteN/A
Jessyka LighthallPhase 3
Sawanpracharak hospitalN/A

See all LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% clinical trials

Pharmacology for LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%

US Patents and Regulatory Information for LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5%

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% lidocaine hydrochloride INJECTABLE;INJECTION 083158-006 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hospira LIDOCAINE HYDROCHLORIDE 0.4% IN DEXTROSE 5% IN PLASTIC CONTAINER lidocaine hydrochloride INJECTABLE;INJECTION 018388-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.